Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study
Top Cited Papers
- 1 June 2005
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 112 (6) , 1035-1047.e9
- https://doi.org/10.1016/j.ophtha.2005.02.007
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: